Beta Bionics, Inc. (BBNX)

Beta Bionics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	30.21	31.58	30.43	26.57	27.68
Cash & Short-Term Investments	30.21	31.58	30.43	26.57	27.68
Cash Growth	-28.85%	3.76%	14.55%	-4.01%	-
Other Current Assets	0.1	0.1	-	-	-
Total Current Assets	30.31	31.68	30.43	26.57	27.68
Total Assets	30.31	31.68	30.43	26.57	27.68
Net Cash (Debt)	30.21	31.58	30.43	26.57	27.68
Net Cash Growth	-4.34%	3.76%	14.55%	-4.01%	-
Net Cash Per Share	0.69	0.78	4.78	5.01	5.54

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Apr 21, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error